Marsico Capital Management LLC Alkermes Plc. Transaction History

Marsico Capital Management LLC

  • $3.46 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$27.94 - $44.61 $1.67 Million - $2.67 Million
-59,843 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$53.61 - $67.26 $596,143 - $747,931
11,120 Added 22.82%
59,843 $3.47 Million
Q4 2017

Feb 14, 2018
BUY
$47.69 - $55.39 $422,962 - $491,253
8,869 Added 22.25%
48,723 $2.67 Million
Q2 2017

Aug 14, 2017
BUY
N/A
39,854
39,854 $2.31 Million

Others Institutions Holding ALKS

# of Institutions
363
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.68B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Marsico Capital Management LLC Portfolio

Follow Marsico Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marsico Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marsico Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email